Literature DB >> 23553314

Neurochemical changes in the rat occipital cortex and hippocampus after repetitive and profound hypoglycemia during the neonatal period: an ex vivo ¹H magnetic resonance spectroscopy study.

Kun Liu1, Xin-Jian Ye, Wen-Yi Hu, Gui-Yan Zhang, Guang-Hui Bai, Liang-Cai Zhao, Jia-Wei He, Huan Zhu, Jian-Bo Shao, Zhi-Han Yan, Hong-Chang Gao.   

Abstract

The brain of a human neonate is more vulnerable to hypoglycemia than that of pediatric and adult patients. Repetitive and profound hypoglycemia during the neonatal period (RPHN) causes brain damage and leads to severe neurologic sequelae. Ex vivo high-resolution (1)H nuclear magnetic resonance (NMR) spectroscopy was carried out in the present study to detect metabolite alterations in newborn and adolescent rats and investigate the effects of RPHN on their occipital cortex and hippocampus. Results showed that RPHN induces significant changes in a number of cerebral metabolites, and such changes are region-specific. Among the 16 metabolites detected by ex vivo (1)H NMR, RPHN significantly increased the levels of creatine, glutamate, glutamine, γ-aminobutyric acid, and aspartate, as well as other metabolites, including succine, taurine, and myo-inositol, in the occipital cortex of neonatal rats compared with the control. By contrast, changes in these neurochemicals were not significant in the hippocampus of neonatal rats. When the rats had developed into adolescence, the changes above were maintained and the levels of other metabolites, including lactate, N-acetyl aspartate, alanine, choline, glycine, acetate, and ascorbate, increased in the occipital cortex. By contrast, most of these metabolites were reduced in the hippocampus. These metabolic changes suggest that complementary mechanisms exist between these two brain areas. RPHN appears to affect occipital cortex and hippocampal activities, neurotransmitter transition, energy metabolism, and other metabolic equilibria in newborn rats; these effects are further aggravated when the newborn rats develop into adolescence. Changes in the metabolism of neurotransmitter system may be an adaptive measure of the central nervous system in response to RPHN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553314     DOI: 10.1007/s12035-013-8446-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  30 in total

1.  Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.

Authors:  M Y Globus; R Busto; W D Dietrich; E Martinez; I Valdes; M D Ginsberg
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

2.  Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus.

Authors:  P Saransaari; S S Oja
Journal:  Int J Dev Neurosci       Date:  1997-04       Impact factor: 2.457

3.  Cerebral metabolic changes in profound, insulin-induced hypoglycemia, and in the recovery period following glucose administration.

Authors:  C D Agardh; J Folbergrová; B K Siesjö
Journal:  J Neurochem       Date:  1978-11       Impact factor: 5.372

4.  Retinal metabolic changes in an experimental model of optic nerve transection by ex vivo 1H magnetic resonance spectroscopy.

Authors:  Shuang Li; Mingming Huang; Xinghua Wang; Xuxia Wang; Fei Chen; Hao Lei; Fagang Jiang
Journal:  Neurochem Res       Date:  2011-08-13       Impact factor: 3.996

5.  Neurochemical changes in brain induced by chronic morphine treatment: NMR studies in thalamus and somatosensory cortex of rats.

Authors:  Yun Xiang; Hongchang Gao; Hang Zhu; Ninglei Sun; Yuanye Ma; Hao Lei
Journal:  Neurochem Res       Date:  2006-10       Impact factor: 3.996

Review 6.  Hypoglycemic brain damage.

Authors:  Roland N Auer
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

7.  Metabolic changes in rat prefrontal cortex and hippocampus induced by chronic morphine treatment studied ex vivo by high resolution 1H NMR spectroscopy.

Authors:  Hongchang Gao; Yun Xiang; Ninglei Sun; Hang Zhu; Yaqiang Wang; Maili Liu; Yuanye Ma; Hao Lei
Journal:  Neurochem Int       Date:  2006-10-30       Impact factor: 3.921

8.  Symptomatic occipital lobe epilepsy following neonatal hypoglycemia.

Authors:  Roberto H Caraballo; Diego Sakr; Marcela Mozzi; Alberto Guerrero; Javier N Adi; Ricardo O Cersósimo; Natalio Fejerman
Journal:  Pediatr Neurol       Date:  2004-07       Impact factor: 3.372

9.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.

Authors:  Olaf Beckonert; Hector C Keun; Timothy M D Ebbels; Jacob Bundy; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

10.  Spectral editing technique for the in vitro and in vivo detection of taurine.

Authors:  D L Hardy; T J Norwood
Journal:  J Magn Reson       Date:  1998-07       Impact factor: 2.229

View more
  9 in total

1.  Ex vivo (1)H nuclear magnetic resonance spectroscopy reveals systematic alterations in cerebral metabolites as the key pathogenetic mechanism of bilirubin encephalopathy.

Authors:  Wenyi Hu; Xiaojie Cheng; Xinjian Ye; Liangcai Zhao; Yanan Huang; Huanle Zhu; Zhihan Yan; Xuebao Wang; Xiaojie Wang; Guanghui Bai; Hongchang Gao
Journal:  Mol Brain       Date:  2014-11-26       Impact factor: 4.041

2.  Early Effect of Amyloid β-Peptide on Hippocampal and Serum Metabolism in Rats Studied by an Integrated Method of NMR-Based Metabolomics and ANOVA-Simultaneous Component Analysis.

Authors:  Yao Du; Hong Zheng; Huanhuan Xia; Liangcai Zhao; Wenyi Hu; Guanghui Bai; Zhihan Yan; Hongchang Gao
Journal:  Biomed Res Int       Date:  2017-01-24       Impact factor: 3.411

3.  Metabolic changes in the midgut of Eri silkworm after Oral administration of 1-deoxynojirimycin: A 1H-NMR-based metabonomic study.

Authors:  Ming-Jie Deng; Xiao-Dong Lin; Chao-Wei Wen; Min-Jian Dong; Qiu-Ting Lin; Shang-Zhi Zhang; Jia-Ping Xu
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

4.  Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model.

Authors:  Yi Lu; Xiaoxia Zhang; Liangcai Zhao; Changwei Yang; Linlin Pan; Chen Li; Kun Liu; Guanghui Bai; Hongchang Gao; Zhihan Yan
Journal:  Front Neurosci       Date:  2018-02-20       Impact factor: 4.677

5.  Metabolic Changes Associated with a Rat Model of Diabetic Depression Detected by Ex Vivo 1H Nuclear Magnetic Resonance Spectroscopy in the Prefrontal Cortex, Hippocampus, and Hypothalamus.

Authors:  Kun Liu; Liangcai Zhao; Wen Xu; Qiuting Lin; Yongjin Zhou; Xiaoyan Huang; Xinjian Ye; Jiawei He; Guanghui Bai; Zhihan Yan; Hongchang Gao
Journal:  Neural Plast       Date:  2018-04-08       Impact factor: 3.599

Review 6.  De novo Synthesis of Glial Glutamate and Glutamine in Young Mice Requires Aspartate Provided by the Neuronal Mitochondrial Aspartate-Glutamate Carrier Aralar/AGC1.

Authors:  Beatriz Pardo; Laura Contreras; Jorgina Satrústegui
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-15       Impact factor: 5.555

7.  Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline.

Authors:  Yongquan Zheng; Yunjun Yang; Baijun Dong; Hong Zheng; Xiaodong Lin; Yao Du; Xiaokun Li; Liangcai Zhao; Hongchang Gao
Journal:  Mol Brain       Date:  2016-04-18       Impact factor: 4.041

8.  An Evaluation of 1-Deoxynojirimycin Oral Administration in Eri Silkworm through Fat Body Metabolomics Based on (1) H Nuclear Magnetic Resonance.

Authors:  Chao-Wei Wen; Xiao-Dong Lin; Min-Jian Dong; Ming-Jie Deng
Journal:  Biomed Res Int       Date:  2016-05-11       Impact factor: 3.411

9.  High Glucose-Induced Cardiomyocyte Death May Be Linked to Unbalanced Branched-Chain Amino Acids and Energy Metabolism.

Authors:  Xi Zhang; Qiuting Lin; Jiuxia Chen; Tingting Wei; Chen Li; Liangcai Zhao; Hongchang Gao; Hong Zheng
Journal:  Molecules       Date:  2018-04-01       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.